Nasotracheal Tube Stenting by Nelaton Catheter in Pediatric Dental Surgery

May 18, 2020 updated by: Amin Mohammed Alansary Amin Ahmed Helwa, Ain Shams University

Nasotracheal Tube Stenting by Nelaton Catheter in Pediatric Dental Surgery , Prospective Randomized Clinical Trial

The value of this study is to compare between stented endotracheal tube with nelaton catheter and non stented tube as regard nasotracheal related complications as epistaxis and nasal cavity injury.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11591
        • Ain Shams University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 9 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Pediatric patients scheduled for dental surgery under general anesthesia age 3-9 years
  • physical status American society of Anesthesiologist(ASA) I orII

Exclusion Criteria:

  • History of recurrent epistaxis
  • Coagulopathy
  • Previous nasal surgery
  • History of nasal trauma
  • Severe renal , hepatic or cardiovascular disease
  • History of drug allergy to the drugs used in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Group I
Endotracheal tube plus Nelaton catheter
Nasotracheal intubation will be done with endotracheal tube
plus nelaton catheter
Other Names:
  • Stent
ACTIVE_COMPARATOR: Group II
Endotracheal tube
Nasotracheal intubation will be done with endotracheal tube

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence and severity of Epistaxis
Time Frame: immediately after nasotracheal intubation
An independent anesthesiologist who did not observe the tube insertion will assess the incidence and severity of epistaxis using a laryngoscope immediately after tube passage through the nasal cavity , four grades to evaluate epistaxis 1- no epistaxis 2- mild epistaxis ,blood apparent on the surface of the tube 3-moderate epistaxis pooling of blood on the posterior pharyngeal wall 4- severe epistaxis , large amount of blood in the pharynx impeding nasotracheal intubation and necessitating urgent orotracheal intubation.
immediately after nasotracheal intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histopathology of the endotracheal tube contents after extubation
Time Frame: immediately after extubation
after extubation the tube contents will be collected in a 5 ml syringe by using sterile swab then tissues will be separated and will be sent for histopathology , the remnant contents will be sent for microscopy , grading the contents as follow 1- secretions only 2- secretions plus blood 3- secretions , blood plus tissues .
immediately after extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 10, 2018

Primary Completion (ACTUAL)

July 1, 2018

Study Completion (ACTUAL)

August 1, 2018

Study Registration Dates

First Submitted

February 24, 2018

First Submitted That Met QC Criteria

March 6, 2018

First Posted (ACTUAL)

March 13, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 19, 2020

Last Update Submitted That Met QC Criteria

May 18, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • FAMSU R 6 / 2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia Intubation Complication

Clinical Trials on Endotracheal tube

Subscribe